Product Information
Name:BNS808
Brand:Targetmol
Description:BNS808 is an orally active, selective CB1R antagonist with an IC50 of 0.8 nM, demonstrating significant selectivity for CB2R and minimal brain penetration. It is being studied for the treatment of obesity and related metabolic complications, such as metabolic dysfunction-associated steatotic liver disease (MASLD). BNS808 reduces drug exposure to the central nervous system, enhancing safety, and minimizes drug interactions through high plasma protein binding.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:548.869
Formula:C25H20Cl3N3O3S
Color/Form:Solid
Technical inquiry about: BNS808
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.